To investigate whether PK7088 stabilizes the Y220C mutant in cancer cells and increases the amount of correctly folded p53 protein, we performed immunofluorescence assays using two conformation-specific antibodies, PAb240 and PAb1620, after 4 h incubation with the small molecule. The gene discussed is TP53; the disease is cancer.